Mushrooms have found their way into our daily lives and have been found to help increase mental clarity, and assist with immune support. “Mushrooms have long been used in Chinese medicine and newer research shows they are the highest dietary source of the antioxidants ergothioneine and glutathione, which help protect the body against the type of damage that can eventually contribute to age-related diseases like cancer, heart disease, Parkinson’s and Alzheimer’s,” says Beth Warren, RDN, author of Secrets of a Kosher Girl. “Mushroom coffees and teas can give anyone a boost, but they may be especially beneficial for those who are dealing with chronic diseases and inflammation.”
According to How Stuff Works, “Functional mushrooms – i.e., mushrooms that are good for you – and coffee make for a natural combination. Both contain essential nutrients and antioxidants and both can be pretty damn tasty when prepared correctly. When added to coffee, one may experience a smoother digestive system (thanks to the natural prebiotics and polysaccharides in mushrooms) and stress management thanks to the adaptogens in mushrooms that mitigate caffeine's jittery side-effects.” Paul Stamets, a well known mycologist and Ted Talk speaker says, “Mushrooms are miniature pharmaceutical factories, and of the thousands of mushroom species in nature, our ancestors and modern scientists have identified several dozen that have a unique combination of talents that improve our health.”
That’s good news for companies like Arev NanoTec Brands Inc. (CSE: AREV)(OTC: AREVF)
Arev NanoTec Brands just announced that its 50% owned Joint Venture company, Absolem Mushroom Extraction Inc., a joint venture owned as to 50% AREV Brands and Absolem Health Inc. has engaged with Professor Robert Rogers to develop formulations and conduct research on certain functional medicinal mushrooms to be extracted by AREV Brands. Nanotechnology and AREV’s proprietary extraction systems are being utilized to develop new methods and product for the benefit of the Joint Venture.
Robert Dale Rogers has been an herbalist for nearly fifty years and is a professional member of the American Herbalist Guild. From 1984 to 2002 he offered a clinical practice, helping support health decisions for over 20,000 clients. He teaches plant and mushroom medicine at Northern Star College, and is a clinical professor in family medicine at the University of Alberta, Canada.
Robert has authored over fifty books on plant medicine, and four on medicinal mushrooms, including The Fungal Pharmacy: The Complete Guide to Medicinal Mushrooms and Lichens of North America (2011), and Medicinal Mushrooms: The Human Clinical Trials (2020).
He has formulated for various nutraceutical and functional food companies; and teaches workshops, and conference seminars throughout Europe and North America. He earned a Bachelor of Science from the University of Alberta, where he is presently an assistant clinical professor in Family Medicine. Robert teaches plant medicine, including plant and mushroom medicine, aromatherapy and flower essences in the Earth Spirit Medicine faculty at the Northern Star College in Edmonton, Alberta, Canada.
Robert is past chair of the Alberta Natural Health Agricultural Network and Community Health Council of Capital Health. He is a Fellow of the International College of Nutrition, past chair of the medicinal mushroom committee of the North American Mycological Association and is on the editorial boards of the International Journal of Medicinal Mushrooms, Fungi magazine and Discovery Phytomedicine.
Mike Withrow CEO of AREV NanoTec stated “We are proud to be the lead scientific team for Absolem who have been working hard on the formulation of functional mushroom products for certain medicinal benefits. Working with Robert on formulation and advancing research will be crucial to the joint venture, as will differentiating the Absolem offering by making peoples well-being the primary focus. Utilizing extracted products and conducting follow on trials to determine efficacy will be a primary focus of this new relationship and we sincerely look forward to working with Robert and the Absolem team on this initiative.”
Other companies using mushrooms include:
Havn Life Sciences (CSE:HAVN)(OTC:HAVLF), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce that it has entered into a definitive agreement to acquire, on the terms and conditions set forth in the Definitive Agreement, all of the outstanding share capital of GCO Packaging and Manufacturing Ltd., which operates a large scale manufacturing, packaging and distribution facility in British Columbia – in exchange for 6,000,000 common shares of Havn Life. Havn Life intends to utilize the Facility to support formulation and manufacturing processes in-house to ensure the highest standards of quality and efficacy. The Acquisition is expected to enable Havn Life to accelerate and scale production of new formulations and products at a single location.
Mindset Pharma Inc. (CSE:MSET), a drug discovery and development company focused on developing next generation psilocybin-inspired medicines and related technologies, is pleased to announce that its common shares have been accepted for listing on the Frankfurt Stock Exchange and commenced trading today under the symbol "9DF". As a result, the Company's common shares are now cross-listed on the CSE and the FSE. James Lanthier, CEO of Mindset, commented, "Listing on the Frankfurt Stock Exchange will provide us an opportunity to grow our shareholder base throughout Europe and allow European investors to follow Mindset's drug development efforts and to be a part of our growth in the psychedelic drug industry.”
New Wave Holdings Corp. (CSE:SPOR)(OTC:TRMNF), an investment issuer that provides capital and support services, is pleased to announce its launch of high quality new functional mushroom wellness collection under Way of Will Inc. Known and loved for their wellness formulas that incorporate natural plant-based ingredients, WAY OF WILL is pleased to announce an upcoming launch of a new product line featuring one of nature's best ingredients: mushrooms. As part of a recent acquisition by New Wave, one of the primary goals is to make WAY OF WILL a more well-rounded and holistic company, beginning with the integration of functional mushrooms into the existing health and wellness product line.
In November 2020, XPhyto Therapeutics Corp. (CSE:XPHY)(OTC:XPHYF), a next-generation bioscience accelerator, is pleased to announce that its German subsidiary, Vektor Pharma TF GmbH, has signed a research agreement with a leading German university for the exclusive development of a proprietary biotechnology process for the industrial manufacture of psilocybin as a certified active pharmaceutical ingredient. The Company has identified a number of psychedelic compounds that are emerging as strong potential candidates for the treatment of mental health related medical indications such as depression, anxiety, addiction, anorexia and post-traumatic stress disorder. The US Food and Drug Administration has twice designated psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) a “breakthrough therapy” for the treatment of severe and treatment-resistant depression due to its potential to provide a major improvement over currently available therapeutics for an unmet medical need.
Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Winning Media is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement Winning Media has been paid three thousand five hundred dollars for advertising and marketing services for Arev NanoTec Brands Inc. by a third party. We own ZERO shares of Arev NanoTec Brands Inc. Please click here for full disclaimer.
Contact Information:
2818047972
[email protected]
